Joe Neguse actually said...
I happen to agree with the dissenting view that was issued back in last November of 2020, and I think the empirical evidence bears that out with a market that is highly concentrated and an American public that is paying higher prices for pharmaceutical drugs than any other Western country.
Context
Neguse criticizes the FTC's approach to pharmaceutical mergers and highlights rising drug prices.
03/17/2021